Nantong Jinghua Pharmaceutical Co Ltd Total Liabilities
Nantong Jinghua Pharmaceutical Co Ltd total liabilities. Based on the latest financial reports, Nantong Jinghua Pharmaceutical Co Ltd (002349) has total liabilities worth CN¥386.24 Million CNY (≈ $56.52 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Nantong Jinghua Pharmaceutical Co Ltd liquidity resilience to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Nantong Jinghua Pharmaceutical Co Ltd (2006–2025)
Total liabilities of Nantong Jinghua Pharmaceutical Co Ltd from 2006 to 2025. This chart illustrates how Nantong Jinghua Pharmaceutical Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore Nantong Jinghua Pharmaceutical Co Ltd (002349) investment intensity to see how much of total assets are deployed in long-term investments.
Nantong Jinghua Pharmaceutical Co Ltd Competitors by Total Liabilities
The table below lists competitors of Nantong Jinghua Pharmaceutical Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Ningbo Construction Co Ltd
SHG:601789
|
China | CN¥33.39 Billion |
|
Gujarat Pipavav Port Limited
NSE:GPPL
|
India | Rs6.35 Billion |
|
Kayne Anderson BDC, Inc.
NYSE:KBDC
|
USA | $1.17 Billion |
|
SP Setia Bhd
KLSE:8664
|
Malaysia | RM10.44 Billion |
|
Guangzhou Dongfang Hotel Co Ltd
SHE:000524
|
China | CN¥1.49 Billion |
|
Winnebago Industries Inc
NYSE:WGO
|
USA | $816.40 Million |
|
Azorim Investment Development and Construction Co Ltd
TA:AZRM
|
Israel | ILA6.66 Billion |
|
Hunan Changgao High Voltage Switchgear Group Co Ltd
SHE:002452
|
China | CN¥1.73 Billion |
Liability Composition Analysis (2006–2025)
This chart breaks down Nantong Jinghua Pharmaceutical Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see 002349 current and non-current assets.
Liquidity & Leverage Metrics
Nantong Jinghua Pharmaceutical Co Ltd Total Liabilities Ratios Explained
Nantong Jinghua Pharmaceutical Co Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 5.43 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.14 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.11 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Nantong Jinghua Pharmaceutical Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Nantong Jinghua Pharmaceutical Co Ltd (2006–2025)
The table below shows the annual total liabilities of Nantong Jinghua Pharmaceutical Co Ltd from 2006 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CN¥421.13 Million ≈ $61.62 Million |
+22.19% |
| 2024-12-31 | CN¥344.66 Million ≈ $50.43 Million |
-9.48% |
| 2023-12-31 | CN¥380.75 Million ≈ $55.72 Million |
-8.90% |
| 2022-12-31 | CN¥417.93 Million ≈ $61.16 Million |
-33.51% |
| 2021-12-31 | CN¥628.54 Million ≈ $91.98 Million |
-6.09% |
| 2020-12-31 | CN¥669.29 Million ≈ $97.94 Million |
-15.67% |
| 2019-12-31 | CN¥793.62 Million ≈ $116.13 Million |
+12.53% |
| 2018-12-31 | CN¥705.27 Million ≈ $103.20 Million |
+18.64% |
| 2017-12-31 | CN¥594.47 Million ≈ $86.99 Million |
+160.88% |
| 2016-12-31 | CN¥227.87 Million ≈ $33.34 Million |
-16.31% |
| 2015-12-31 | CN¥272.27 Million ≈ $39.84 Million |
-22.64% |
| 2014-12-31 | CN¥351.96 Million ≈ $51.50 Million |
+6.98% |
| 2013-12-31 | CN¥328.99 Million ≈ $48.14 Million |
+35.47% |
| 2012-12-31 | CN¥242.84 Million ≈ $35.54 Million |
+68.37% |
| 2011-12-31 | CN¥144.23 Million ≈ $21.11 Million |
+115.39% |
| 2010-12-31 | CN¥66.96 Million ≈ $9.80 Million |
-19.57% |
| 2009-12-31 | CN¥83.26 Million ≈ $12.18 Million |
+7.72% |
| 2008-12-31 | CN¥77.29 Million ≈ $11.31 Million |
-28.60% |
| 2007-12-31 | CN¥108.25 Million ≈ $15.84 Million |
-15.55% |
| 2006-12-31 | CN¥128.18 Million ≈ $18.76 Million |
-- |
About Nantong Jinghua Pharmaceutical Co Ltd
Jinghua Pharmaceutical Group Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of pharmaceuticals in China and internationally. The company offers active pharmaceutical ingredients (APIs) and intermediates, chemical and pharmaceutical intermediates, Chinese medicinal herbs and materials, health products, and Western medicine products. It also pr… Read more